Global Gastrointestinal Therapeutics Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Gastrointestinal Therapeutics Revenue
• 1.4 Market by Type
  • 1.4.1 Global Gastrointestinal Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Oral
  • 1.4.3 Parenteral
• 1.5 Market by Application
  • 1.5.1 Global Gastrointestinal Therapeutics Market Share by Application: 2020 VS 2026
  • 1.5.2 IBD
  • 1.5.3 Irritable Bowel Syndrome (IBS)
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Gastrointestinal Therapeutics Market Perspective (2015-2026)
• 2.2 Global Gastrointestinal Therapeutics Growth Trends by Regions
  • 2.2.1 Gastrointestinal Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Gastrointestinal Therapeutics Historic Market Share by Regions (2015-2020)
  • 2.2.3 Gastrointestinal Therapeutics Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Gastrointestinal Therapeutics Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Gastrointestinal Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Gastrointestinal Therapeutics Players by Market Size
  • 3.1.1 Global Top Gastrointestinal Therapeutics Players by Revenue (2015-2020)
  • 3.1.2 Global Gastrointestinal Therapeutics Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Gastrointestinal Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Gastrointestinal Therapeutics Market Concentration Ratio
  • 3.2.1 Global Gastrointestinal Therapeutics Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Gastrointestinal Therapeutics Revenue in 2019
• 3.3 Gastrointestinal Therapeutics Key Players Head office and Area Served
• 3.4 Key Players Gastrointestinal Therapeutics Product Solution and Service
• 3.5 Date of Enter into Gastrointestinal Therapeutics Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Gastrointestinal Therapeutics Historic Market Size by Type (2015-2020)
• 4.2 Global Gastrointestinal Therapeutics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Gastrointestinal Therapeutics Market Size by Application (2015-2020)
• 5.2 Global Gastrointestinal Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Gastrointestinal Therapeutics Market Size (2015-2020)
• 6.2 Gastrointestinal Therapeutics Key Players in North America (2019-2020)
• 6.3 North America Gastrointestinal Therapeutics Market Size by Type (2015-2020)
• 6.4 North America Gastrointestinal Therapeutics Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Gastrointestinal Therapeutics Market Size (2015-2020)
• 7.2 Gastrointestinal Therapeutics Key Players in Europe (2019-2020)
• 7.3 Europe Gastrointestinal Therapeutics Market Size by Type (2015-2020)
• 7.4 Europe Gastrointestinal Therapeutics Market Size by Application (2015-2020)

8 China

• 8.1 China Gastrointestinal Therapeutics Market Size (2015-2020)
• 8.2 Gastrointestinal Therapeutics Key Players in China (2019-2020)
• 8.3 China Gastrointestinal Therapeutics Market Size by Type (2015-2020)
• 8.4 China Gastrointestinal Therapeutics Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Gastrointestinal Therapeutics Market Size (2015-2020)
• 9.2 Gastrointestinal Therapeutics Key Players in Japan (2019-2020)
• 9.3 Japan Gastrointestinal Therapeutics Market Size by Type (2015-2020)
• 9.4 Japan Gastrointestinal Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Gastrointestinal Therapeutics Market Size (2015-2020)
• 10.2 Gastrointestinal Therapeutics Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Gastrointestinal Therapeutics Market Size by Type (2015-2020)
• 10.4 Southeast Asia Gastrointestinal Therapeutics Market Size by Application (2015-2020)

11 India

• 11.1 India Gastrointestinal Therapeutics Market Size (2015-2020)
• 11.2 Gastrointestinal Therapeutics Key Players in India (2019-2020)
• 11.3 India Gastrointestinal Therapeutics Market Size by Type (2015-2020)
• 11.4 India Gastrointestinal Therapeutics Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Gastrointestinal Therapeutics Market Size (2015-2020)
• 12.2 Gastrointestinal Therapeutics Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Gastrointestinal Therapeutics Market Size by Type (2015-2020)
• 12.4 Central & South America Gastrointestinal Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 AbbVie
  • 13.1.1 AbbVie Company Details
  • 13.1.2 AbbVie Business Overview
  • 13.1.3 AbbVie Gastrointestinal Therapeutics Introduction
  • 13.1.4 AbbVie Revenue in Gastrointestinal Therapeutics Business (2015-2020))
  • 13.1.5 AbbVie Recent Development
• 13.2 Allergan
  • 13.2.1 Allergan Company Details
  • 13.2.2 Allergan Business Overview
  • 13.2.3 Allergan Gastrointestinal Therapeutics Introduction
  • 13.2.4 Allergan Revenue in Gastrointestinal Therapeutics Business (2015-2020)
  • 13.2.5 Allergan Recent Development
• 13.3 Johnson & Johnson
  • 13.3.1 Johnson & Johnson Company Details
  • 13.3.2 Johnson & Johnson Business Overview
  • 13.3.3 Johnson & Johnson Gastrointestinal Therapeutics Introduction
  • 13.3.4 Johnson & Johnson Revenue in Gastrointestinal Therapeutics Business (2015-2020)
  • 13.3.5 Johnson & Johnson Recent Development
• 13.4 Takeda
  • 13.4.1 Takeda Company Details
  • 13.4.2 Takeda Business Overview
  • 13.4.3 Takeda Gastrointestinal Therapeutics Introduction
  • 13.4.4 Takeda Revenue in Gastrointestinal Therapeutics Business (2015-2020)
  • 13.4.5 Takeda Recent Development
• 13.5 Novartis
  • 13.5.1 Novartis Company Details
  • 13.5.2 Novartis Business Overview
  • 13.5.3 Novartis Gastrointestinal Therapeutics Introduction
  • 13.5.4 Novartis Revenue in Gastrointestinal Therapeutics Business (2015-2020)
  • 13.5.5 Novartis Recent Development
• 13.6 Pfizer
  • 13.6.1 Pfizer Company Details
  • 13.6.2 Pfizer Business Overview
  • 13.6.3 Pfizer Gastrointestinal Therapeutics Introduction
  • 13.6.4 Pfizer Revenue in Gastrointestinal Therapeutics Business (2015-2020)
  • 13.6.5 Pfizer Recent Development
• 13.7 Merck
  • 13.7.1 Merck Company Details
  • 13.7.2 Merck Business Overview
  • 13.7.3 Merck Gastrointestinal Therapeutics Introduction
  • 13.7.4 Merck Revenue in Gastrointestinal Therapeutics Business (2015-2020)
  • 13.7.5 Merck Recent Development
• 13.8 F. Hoffmann-La Roche
  • 13.8.1 F. Hoffmann-La Roche Company Details
  • 13.8.2 F. Hoffmann-La Roche Business Overview
  • 13.8.3 F. Hoffmann-La Roche Gastrointestinal Therapeutics Introduction
  • 13.8.4 F. Hoffmann-La Roche Revenue in Gastrointestinal Therapeutics Business (2015-2020)
  • 13.8.5 F. Hoffmann-La Roche Recent Development
• 13.9 Eli Lilly
  • 13.9.1 Eli Lilly Company Details
  • 13.9.2 Eli Lilly Business Overview
  • 13.9.3 Eli Lilly Gastrointestinal Therapeutics Introduction
  • 13.9.4 Eli Lilly Revenue in Gastrointestinal Therapeutics Business (2015-2020)
  • 13.9.5 Eli Lilly Recent Development
• 13.10 AstraZeneca
  • 13.10.1 AstraZeneca Company Details
  • 13.10.2 AstraZeneca Business Overview
  • 13.10.3 AstraZeneca Gastrointestinal Therapeutics Introduction
  • 13.10.4 AstraZeneca Revenue in Gastrointestinal Therapeutics Business (2015-2020)
  • 13.10.5 AstraZeneca Recent Development
• 13.11 Procter & Gamble
  • 10.11.1 Procter & Gamble Company Details
  • 10.11.2 Procter & Gamble Business Overview
  • 10.11.3 Procter & Gamble Gastrointestinal Therapeutics Introduction
  • 10.11.4 Procter & Gamble Revenue in Gastrointestinal Therapeutics Business (2015-2020)
  • 10.11.5 Procter & Gamble Recent Development
• 13.12 Tillotts Pharma
  • 10.12.1 Tillotts Pharma Company Details
  • 10.12.2 Tillotts Pharma Business Overview
  • 10.12.3 Tillotts Pharma Gastrointestinal Therapeutics Introduction
  • 10.12.4 Tillotts Pharma Revenue in Gastrointestinal Therapeutics Business (2015-2020)
  • 10.12.5 Tillotts Pharma Recent Development
• 13.13 Takeda
  • 10.13.1 Takeda Company Details
  • 10.13.2 Takeda Business Overview
  • 10.13.3 Takeda Gastrointestinal Therapeutics Introduction
  • 10.13.4 Takeda Revenue in Gastrointestinal Therapeutics Business (2015-2020)
  • 10.13.5 Takeda Recent Development
• 13.14 GlaxoSmithKline
  • 10.14.1 GlaxoSmithKline Company Details
  • 10.14.2 GlaxoSmithKline Business Overview
  • 10.14.3 GlaxoSmithKline Gastrointestinal Therapeutics Introduction
  • 10.14.4 GlaxoSmithKline Revenue in Gastrointestinal Therapeutics Business (2015-2020)
  • 10.14.5 GlaxoSmithKline Recent Development
• 13.15 Amgen
  • 10.15.1 Amgen Company Details
  • 10.15.2 Amgen Business Overview
  • 10.15.3 Amgen Gastrointestinal Therapeutics Introduction
  • 10.15.4 Amgen Revenue in Gastrointestinal Therapeutics Business (2015-2020)
  • 10.15.5 Amgen Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer